)
Kura Oncology (KURA) investor relations material
Kura Oncology Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 4, 2026, to be held virtually for shareholders of record as of April 6, 2026.
Shareholders are encouraged to review proxy materials online and vote using a provided control number.
Voting matters and shareholder proposals
Election of three Class III directors for three-year terms: Diane Parks, Mary T. Szela, and Michael J. Vasconcelles, M.D.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation (Say-on-Pay) and preferred frequency for future Say-on-Pay votes.
Approval of amendments to the 2014 Equity Incentive Plan and 2015 Employee Stock Purchase Plan.
Provision to transact other business as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting "FOR" all director nominees and all proposals except for proposal 4, where "1 YEAR" is recommended for Say-on-Pay frequency.
- Annual meeting to address director elections, compensation, equity plan amendments, and ESG initiatives.KURA
Proxy filing10 Apr 2026 - Komzifti and ziftomenib advance with strong launch, global trials, and promising pipeline updates.KURA
Barclays 28th Annual Global Healthcare Conference12 Mar 2026 - Rapid market access and robust pipeline drive growth and leadership ambitions in precision oncology.KURA
Leerink Global Healthcare Conference 202610 Mar 2026 - KOMZIFTI launch and pipeline progress drive growth, targeting major cancer markets.KURA
Corporate presentation5 Mar 2026 - Early launch success, strong revenue, and robust cash position support pivotal clinical progress.KURA
Q4 20255 Mar 2026 - Komzifti's launch and broad clinical pipeline drive growth, with strong cash reserves supporting expansion.KURA
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - Breakthrough therapy status, 35% CR in AML, and $491.5M cash drive strong clinical momentum.KURA
Q2 20242 Feb 2026 - Pivotal AML trial enrollment finished; top-line ziftomenib data due early 2025.KURA
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Ziftomenib's strong safety and broad potential drive pivotal trials in AML, GIST, and diabetes.KURA
2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
Next Kura Oncology earnings date
Next Kura Oncology earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage